MCK
McKesson Corporation
October 1, 2026 · market open
- Rarity
- 2.17
- Peak move
- +7.82%
- Float cap
- $102.5B
McKesson Corporation is a diversified healthcare services company that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments. It distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceuticals and other healthcare products in the U.S. and Canada, and provides medical-surgical supplies, oncology and specialty provider services, and prescription technology solutions.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
4 events · 0 from SEC or newswire · 0 timed with the move- Key event
major_contractMcKesson signed an agreement in principle with CVS Health to extend their pharmaceutical distribution partnership through June 2032, covering mail order, specialty and retail pharmacies and distribution centers.
- Key event
peer_disclosureCardinal Health extended its pharmaceutical distribution agreement with CVS Health through June 2032 and reiterated fiscal-year adjusted EPS growth guidance of 13% to 15%.
- Key event
guidance_changeAlongside the CVS Health distribution extension, McKesson reaffirmed fiscal 2027 adjusted EPS guidance of $44.20 to $45.00 and long-term adjusted EPS growth of 13% to 16%, with updates due at its Nov. 4, 2026 earnings call.
analyst_ratingBofA reiterated Buy ratings on McKesson and Cardinal Health after both extended their CVS Health distribution agreements, calling the extensions a 'clearing event' that retains the status quo.